Stephens Consulting, LLC
- SEC CIK
- 0001961632
- Latest filing
- Jan 13, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Stephens Consulting, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q4 2025 holdings
- Shares (Q4 2025)
- 67
- Value
- $275
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 67 | $275 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 67 | $327 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 67 | $340 | <0.1% | −120−64.2% | Reduced | Holders |
| Q1 2025 | 187 | $990 | <0.1% | +120+179.1% | Added | Holders |
| Q4 2024 | 67 | $453 | <0.1% | +67 | New | Holders |